View All News

Lygos raises $13MM Series A financing

Lygos, today is excited to announce the closing of $13 million in Series A financing led by IA Ventures and OS Fund. The funds will be used, in part, to build the manufacturing team and QC infrastructure while also fueling the innovation engine powering development of Lygos’ next set of biochemicals.

Read more:

“Synthetic biology startup Lygos raises $13 million from OS Fund and IA Ventures to make cleaner chemicals.” TechCrunch (Dec. 2016).


More News
September 16, 2019
Lygos Secures Strategic Investment from CJ CheilJedang to Accelerate Growth in Bioengineering Industries
September 5, 2019
Lygos Upgrades Technology Capabilities to Accelerate Microbial Cell Factory Development Timelines
July 8, 2019
Lygos Announces Bio-DEM™ Product Qualified at Metric Ton Scale for Sirrus’ Chemilian™ and Forza™ Product Lines